20/08/01 14:28:40.88 4lpenoAw.net
DUBAI – July 15, 2020 – Healthcare solutions provider Global Response Aid (GRA) said the anti-viral drug Avigan® produced encouraging results in a recent multi-center clinical study led by Japan’s Fujita Health University,
showing a discernible trend in reducing fevers and viral loads in early-stage COVID-19 patients.
同じ藤田の検証結果でも日本のマスコミはアビガンは効かないと報道し、
世界的な医療会社はアビガン有効と判断している。